CN104327064B - 一种具有抗肿瘤活性的吖啶-1,3,4-噁二唑类化合物及其制备方法和用途 - Google Patents
一种具有抗肿瘤活性的吖啶-1,3,4-噁二唑类化合物及其制备方法和用途 Download PDFInfo
- Publication number
- CN104327064B CN104327064B CN201410522396.6A CN201410522396A CN104327064B CN 104327064 B CN104327064 B CN 104327064B CN 201410522396 A CN201410522396 A CN 201410522396A CN 104327064 B CN104327064 B CN 104327064B
- Authority
- CN
- China
- Prior art keywords
- formula
- acridine
- compound
- solvent
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410522396.6A CN104327064B (zh) | 2014-09-30 | 2014-09-30 | 一种具有抗肿瘤活性的吖啶-1,3,4-噁二唑类化合物及其制备方法和用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410522396.6A CN104327064B (zh) | 2014-09-30 | 2014-09-30 | 一种具有抗肿瘤活性的吖啶-1,3,4-噁二唑类化合物及其制备方法和用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104327064A CN104327064A (zh) | 2015-02-04 |
CN104327064B true CN104327064B (zh) | 2017-01-11 |
Family
ID=52401883
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410522396.6A Active CN104327064B (zh) | 2014-09-30 | 2014-09-30 | 一种具有抗肿瘤活性的吖啶-1,3,4-噁二唑类化合物及其制备方法和用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104327064B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111057004B (zh) * | 2019-11-04 | 2023-10-31 | 宁波大学 | 一种n-邻取代苯基苯甲酰胺-4-甲氨基吖啶类化合物及其制备方法和用途 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102146056B (zh) * | 2010-02-10 | 2013-05-29 | 清华大学深圳研究生院 | N-苄基-吖啶酮及其衍生物以及它们的制备方法与应用 |
-
2014
- 2014-09-30 CN CN201410522396.6A patent/CN104327064B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN104327064A (zh) | 2015-02-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104326979B (zh) | 2-甲基-9-吖啶(对甲氧基苯甲酰胺基)硫脲及其制备方法和用途 | |
CN107746418B (zh) | 一种靶向于肝癌的9-氯-1,2,3,4-四氢吖啶-铂(ii)配合物的合成及其应用 | |
CN113072591B (zh) | 铱配合物及其合成方法和应用 | |
CN111039990B (zh) | 低毒性的铱配合物及其合成方法和应用 | |
CN107021945B (zh) | 一种含哌嗪酰胺类杨梅素类衍生物及其制备方法 | |
CN111116667B (zh) | 基于8-羟基喹啉衍生物和1-苯基吡唑铱二聚体构筑的铱配合物及其合成方法和应用 | |
CN101624376A (zh) | 取代酰肼类化合物及其应用 | |
CN109970679A (zh) | 丹皮酚噻唑衍生物及其制备方法和应用 | |
CN104327064B (zh) | 一种具有抗肿瘤活性的吖啶-1,3,4-噁二唑类化合物及其制备方法和用途 | |
CN104059062B (zh) | 含苯并噻唑和三唑双杂环的稠环化合物及其应用 | |
CN104098524B (zh) | 1-间甲氧基苯甲酰基-3-苯基-1,4-二氢-1,2,4,5-四嗪及制备和应用 | |
CN103804388A (zh) | 4β-氮取代呋喃叔胺类鬼臼毒素衍生物及其制备方法与应用 | |
CN108017608A (zh) | 一类黄酮衍生物及其制备方法和用途 | |
CN104327063B (zh) | 一种吖啶噁二唑类衍生物及其制备方法和用途 | |
CN106543155B (zh) | 作为极光激酶抑制剂的查尔酮及黄酮类衍生物 | |
CN103709146B (zh) | 一类含苯并咪唑结构的喹啉-4-胺衍生物、其制法及医药用途 | |
CN112225733B (zh) | 一种含1,3,4-噻二唑吡啶-2-酮衍生物的制备方法和作为抗癌药物的应用 | |
CN103435574B (zh) | 一种巯基苯并噻唑取代的苊并杂环类化合物及其应用 | |
CN105481852A (zh) | 7-苯并[b]-[1,10]邻菲咯啉对甲氧基苯甲酰胺基硫脲及其制备方法和用途 | |
CN106890174A (zh) | 基于姜黄素结构的小分子杂环化合物及其用于制备抗肿瘤药物的应用 | |
CN107602578B (zh) | 一种含哒嗪酮结构的d-缬氨酸取代去甲斑蝥素衍生物的制备方法及其应用 | |
CN107722029B (zh) | 一种含哒嗪酮结构的d-亮氨酸取代去甲斑蝥素衍生物的制备方法及其应用 | |
CN104725364B (zh) | 6,7‑二甲氧基‑喹唑啉‑4‑胺衍生物、其制备方法及医药用途 | |
CN107043344B (zh) | 联苯乙酮腙-n-甲基-3-吲哚甲醛西弗碱的制备、结构和用途 | |
CN103880793A (zh) | 含呋喃亚胺类化合物及其制备方法和用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20201221 Address after: Room 503, building 3, No. 133, development avenue, Tongxiang Economic Development Zone, Tongxiang City, Jiaxing City, Zhejiang Province Patentee after: ZHEJIANG MAIZHI NETWORK TECHNOLOGY Co.,Ltd. Address before: 530213 No. 13 Wuhe Avenue, Qingxiu District, Nanning City, Guangxi Zhuang Autonomous Region Patentee before: Guangxi University of Chinese Medicine |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20221108 Address after: Room 403, No. 35, Lane 55, South Jiangyang Road, Hongkou District, Shanghai 200080 Patentee after: Liu Tianjin Patentee after: Liu Kainian Address before: Room 503, building 3, No. 133, development avenue, Tongxiang Economic Development Zone, Tongxiang City, Jiaxing City, Zhejiang Province Patentee before: ZHEJIANG MAIZHI NETWORK TECHNOLOGY CO.,LTD. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230227 Address after: 261000 room 209, e-commerce Industrial Park, north of Dongfeng East Street and west of Weizhou Road, Kuiwen District, Weifang City, Shandong Province Patentee after: Weifang Jitao Medical Technology Co.,Ltd. Address before: Room 403, No. 35, Lane 55, South Jiangyang Road, Hongkou District, Shanghai 200080 Patentee before: Liu Tianjin Patentee before: Liu Kainian |